A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study
NEUROPSYCHOPHARMACOLOGY(2014)
关键词
Biomarker risk assignment algorithm,mild cognitive impairment due to AD,cognitive domains in AD
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要